Supplementary Table S2 from Design and Evaluation of ZD06519, a Novel Camptothecin Payload for Antibody Drug Conjugates
2024 · 0 citations
https://doi.org/10.1158/1535-7163.25735676.v1
M
Manuel Lasalle
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
39
Papers
129
Citations
6
h-index
4
i10-index
Manuel Lasalle is an academic researcher. The author has contributed to research in topics: HER2/EGFR in Cancer Research & Monoclonal and Polyclonal Antibodies Research & Cancer therapeutics and mechanisms. The author has an h-index of 6, co-authored 34 publications.
ORCID: 0000-0001-5597-3289Papers by this author
worksSupplementary Figure S2 from Design and Evaluation of ZD06519, a Novel Camptothecin Payload for Antibody Drug Conjugates
2024 · 0 citations
https://doi.org/10.1158/1535-7163.25735688
Supplementary Table S2 from Design and Evaluation of ZD06519, a Novel Camptothecin Payload for Antibody Drug Conjugates
2024 · 0 citations
https://doi.org/10.1158/1535-7163.25735676
Supplementary Table S3 from Design and Evaluation of ZD06519, a Novel Camptothecin Payload for Antibody Drug Conjugates
2024 · 0 citations
https://doi.org/10.1158/1535-7163.25735670
Synthetic Procedures from Design and Evaluation of ZD06519, a Novel Camptothecin Payload for Antibody Drug Conjugates
2024 · 0 citations
https://doi.org/10.1158/1535-7163.25735667
Supplementary Table S1 from Design and Evaluation of ZD06519, a Novel Camptothecin Payload for Antibody Drug Conjugates
2024 · 0 citations
https://doi.org/10.1158/1535-7163.25735679.v1
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat